Liaoning Cheng Da (600739) Stock Overview

Liaoning Cheng Da Co., Ltd. engages in supply chain trade, biopharmaceuticals, financial investment, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles and clothing, as well as trading of bulk commodities, such as coal, steel, and aquatic and agricultural products; and investment in securities, insurance and funds, and other financial service enterprises. It also offers human rabies vaccine and human JE inactivated vaccines, as well as exports its products to Egypt and Thailand; and engages in the investment in medical industry, and medical enterprise management consulting. In addition, the company is involved in the provision of medical, computer software and hardware technology development, technology consulting, technology transfer, technical services; and sale of medical equipment and other businesses. Further, it engages in the mining, production and sale of shale oil; and research and development, design, cutting-edge marketing, multinational procurement, and logistics services. Liaoning Cheng Da Co., Ltd. was founded in 1991 and is based in Dalian, China.